These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14769253)

  • 1. Formulation of fast release glibenclamide liquid and semi-solid matrix filled capsules.
    Galal S; El-Massik M; Abdallah O; Daabis N
    Acta Pharm; 2003 Mar; 53(1):57-64. PubMed ID: 14769253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants.
    Cirri M; Maestrelli F; Corti G; Mura P; Valleri M
    Drug Deliv; 2007 Apr; 14(4):247-55. PubMed ID: 17497357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of spray congealed microparticles with self-emulsifying ability for enhanced glibenclamide dissolution performance.
    Albertini B; Sabatino MD; Melegari C; Passerini N
    J Microencapsul; 2015; 32(2):181-92. PubMed ID: 25423165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S; El Massik MA; Abdallah OY; Daabis NA
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A review on liquid-filled hard gelatin capsules].
    Ma JH; Yang M; Zeng M; Chen XM; Lan J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K; Schreder SA; Dressman J
    Eur J Pharm Biopharm; 2006 Apr; 62(3):227-34. PubMed ID: 16246538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.
    Kochling JD; Miao H; Young CR; Looker AR; Shannon M; Montgomery ER
    J Pharm Biomed Anal; 2007 Apr; 43(5):1638-46. PubMed ID: 17224256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
    da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2013 May; 39(5):791-8. PubMed ID: 22871141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of an ideal formulation of glibenclamide by solid dispersion techniques.
    Ghosh LK; Thakur RS; Sharma PK; Ghosh NC; Gupta BK
    Boll Chim Farm; 1998 Jan; 137(1):26-9. PubMed ID: 9595831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.